|
|
9920 Belward Campus Drive
Rockville, MD 20850 USA
phone:240 268 2000
fax:
|
|
| Symbol |
NVAX |
| Exchange |
NASDAQ |
| Founded |
1989 |
| Employees |
121 |
|
|
| www.novavax.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Vaccines for infectious diseases |
|
| Management |
| Rahul Singhvi, Sc.D., M.B.A., President and Chief Executive Officer; John J. Trizzino, B.S., M.B.A., Senior Vice President of International and Government Alliances; Gale Smith, Ph.D., Vice President, Vaccine Development; Thomas S. Johnston, B.S., M.B.A, Vice President, Strategy; Frederick W. Driscoll, Vice President, Chief Financial Officer and Treasurer |
| |
|
|
|
|
|
|
|
| Keywords |
| pandemic, holistic, vaccines, syncytial, varicella |
|
|
|
| Description |
|
Novavax is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The company produces these VLP based potent, recombinant vaccines utilizing a new and efficient manufacturing approach.Our world-class scientific team is using virus-like particle (VLP) technology to tackle influenza viruses � including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccines designed to protect against various circulating strains of avian influenza as well as seasonal flu, Respiratory Syncytial Virus (RSV) and Varicella Zoster Virus (VZV). |
|
| Products / Services |
Services include, but are not limited to, experimental vaccine development, large-scale virus seed pool production in different tissue culture systems and embryonated hens' eggs, the production and testing of tissue cell banks, final container filling of experimental vaccines in ampules, cryules and aluminum-crimped cap vials, vaccine in vivo and in vitro safety testing, and microbiological sterility testing.
|
|
| Market / Customers |
The group markets, sells and distributes a line of ethical pharmaceuticals and pre-natal vitamins, including certain hormones, anti-bacterial and anti-viral products and vaccine adjuvant. They also conduct research and development on prevenative and therapeutic vaccines for a variety of infectious diseases including human papillomavrus.
|
|
| Competitors / Substitutes / Alternatives |
Androgen Corp., Estromex
|
|
| Strategy |
Novavax utilizes its unique drug delivery capacity to dominate the estrogen market and other markets such as infectious diseases.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
